{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T07:19:33Z","timestamp":1788679173759,"version":"build-2803163510"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jtauto.2025.100291","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T06:39:07Z","timestamp":1746254347000},"page":"100291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Autoantibodies as prognostic markers in rheumatoid arthritis"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3805-2290","authenticated-orcid":false,"given":"Carl","family":"Turesson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"R\u00f6nnelid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alf","family":"Kastbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jtauto.2025.100291_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1297-319X(00)00247-5","article-title":"The first description of rheumatoid arthritis. Unabridged text of the doctoral dissertation presented in 1800","volume":"68","author":"Landr\u00e9-Beauvais","year":"2001","journal-title":"Jt. Bone Spine"},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/03009742.2021.1894824","article-title":"Early description of polyarthritis possibly representing rheumatoid arthritis given by a patient, as recorded in a textbook on gout from 1788","volume":"51","author":"Sch\u00e4fer","year":"2022","journal-title":"Scand. J. Rheumatol."},{"issue":"9","key":"10.1016\/j.jtauto.2025.100291_bib3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/ard.2003.019877","article-title":"Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis","volume":"63","author":"Vallbracht","year":"2004","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100291_bib4","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1172\/JCI116713","article-title":"The cytokeratin filament-aggregating protein filaggrin is the target of the so-called \"antikeratin antibodies,\" autoantibodies specific for rheumatoid arthritis","volume":"92","author":"Simon","year":"1993","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.jtauto.2025.100291_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrrheum.2011.76","article-title":"Anti-CCP antibodies: the past, the present and the future","volume":"7","author":"van Venrooij","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100291_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cca.2014.07.032","article-title":"Clinical evaluation of a novel chemiluminescent immunoassay for the detection of anti-citrullinated peptide antibodies","volume":"437","author":"Webb","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"8","key":"10.1016\/j.jtauto.2025.100291_bib8","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/art.22817","article-title":"Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis","volume":"56","author":"Bang","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100291_bib9","first-page":"311","article-title":"International reference preparation of rheumatoid arthritis serum","volume":"42","author":"Anderson","year":"1970","journal-title":"Bull. World Health Organ."},{"issue":"9","key":"10.1016\/j.jtauto.2025.100291_bib10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0019-2791(71)90454-X","article-title":"Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin","volume":"8","author":"Engvall","year":"1971","journal-title":"G. Immunochemistry."},{"issue":"12","key":"10.1016\/j.jtauto.2025.100291_bib12","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1136\/ard-2024-226169","article-title":"New WHO ACPA standard enables standardisation among anti-CCP2 assays, but not other ACPA assays using different antigens","volume":"83","author":"Van Hoovels","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100291_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.jtauto.2025.100291_bib14","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/art.10436","article-title":"Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: a highly effective test for the diagnosis of rheumatoid arthritis","volume":"46","author":"Vincent","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.jtauto.2025.100291_bib15","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.jtauto.2025.100291_bib16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/annrheumdis-2017-212365","article-title":"Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR\/EULAR classification of rheumatoid arthritis","volume":"77","author":"Van Hoovels","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.jtauto.2025.100291_bib17","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1136\/annrheumdis-2011-200693","article-title":"Preliminary evaluation of the first international reference preparation for anticitrullinated peptide antibodies","volume":"71","author":"Bizzaro","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13317-020-0127-3","article-title":"The perspective on standardisation and harmonisation: the viewpoint of the EASI president","volume":"11","author":"Damoiseaux","year":"2020","journal-title":"Auto Immun Highlights"},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-002099","article-title":"Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein\/peptide antibodies test results","volume":"8","author":"Van Hoovels","year":"2022","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.jtauto.2025.100291_bib20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0002-9343(91)90190-9","article-title":"The rheumatoid factor: an analysis of clinical utility","volume":"91","author":"Shmerling","year":"1991","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/03009742.2019.1609079","article-title":"Predictive values of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in relation to serological aspects of the ACR\/EULAR 2010 classification criteria for rheumatoid arthritis","volume":"49","author":"Tenstad","year":"2020","journal-title":"Scand. J. Rheumatol."},{"issue":"50","key":"10.1016\/j.jtauto.2025.100291_bib22","first-page":"4092","article-title":"[Antibodies against citrullinated proteins--a breakthrough in rheumatologic diagnostics]","volume":"101","author":"R\u00f6nnelid","year":"2004","journal-title":"Lakartidningen"},{"key":"10.1016\/j.jtauto.2025.100291_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2022.100142","article-title":"Impact of autoimmune serology test results on RA classification and diagnosis","volume":"5","author":"Van Hoovels","year":"2022","journal-title":"J Transl Autoimmun"},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103421","article-title":"Should ACR\/EULAR criteria be revised changing the RF and ACPA scores?","volume":"23","author":"Steiner","year":"2024","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100291_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003851","article-title":"Classification of rheumatoid arthritis: is it time to revise the criteria?","volume":"10","author":"Steiner","year":"2024","journal-title":"RMD Open"},{"issue":"42","key":"10.1016\/j.jtauto.2025.100291_bib26","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"7","key":"10.1016\/j.jtauto.2025.100291_bib27","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/art.23596","article-title":"Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis","volume":"58","author":"Harris","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.jtauto.2025.100291_bib28","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/90696","article-title":"Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease","volume":"2","author":"Schaller","year":"2001","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.jtauto.2025.100291_bib29","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/annrheumdis-2016-210873","article-title":"Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up","volume":"76","author":"Manivel","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2025.100291_bib30","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar551","article-title":"Autoantibodies in rheumatoid arthritis and their clinical significance","volume":"4","author":"Steiner","year":"2002","journal-title":"Arthritis Res."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100291_bib31","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.38969","article-title":"Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis","volume":"67","author":"Thiele","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.jtauto.2025.100291_bib32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/03009742.2024.2386756","article-title":"Keep a closer eye on 'seronegative rheumatoid arthritis'","volume":"53","author":"Sokka-Isler","year":"2024","journal-title":"Scand. J. Rheumatol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib33","first-page":"37","article-title":"Does early seronegative arthritis develop into rheumatoid arthritis? A 10-year observational study","volume":"37","author":"Paalanen","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"issue":"11","key":"10.1016\/j.jtauto.2025.100291_bib34","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.mayocp.2019.05.023","article-title":"Evidence of diagnostic and treatment delay in seronegative rheumatoid arthritis: missing the window of opportunity","volume":"94","author":"Coffey","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jtauto.2025.100291_bib35","article-title":"Long-term outcomes in seronegative rheumatoid arthritis [abstract]","volume":"76","author":"Kimbrough","year":"2024","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100291_bib36","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ajhg.2019.08.002","article-title":"Distinct HLA associations with rheumatoid arthritis subsets defined by serological subphenotype","volume":"105","author":"Terao","year":"2019","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib37","first-page":"47","article-title":"Current tobacco smoking, formal education, and the risk of rheumatoid arthritis","volume":"26","author":"Uhlig","year":"1999","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.jtauto.2025.100291_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/ar2022","article-title":"Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides","volume":"8","author":"Pedersen","year":"2006","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100291_bib40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/ard.2011.200059","article-title":"Early menopause is an independent predictor of rheumatoid arthritis","volume":"71","author":"Pikwer","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100291_bib41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/annrheumdis-2012-202781","article-title":"Association between testosterone levels and risk of future rheumatoid arthritis in men: a population-based case-control study","volume":"73","author":"Pikwer","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.jtauto.2025.100291_bib42","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2003.014233","article-title":"Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP)","volume":"63","author":"Forslind","year":"2004","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13075-018-1575-2","article-title":"Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis","volume":"20","author":"Rydell","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.jtauto.2025.100291_bib44","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/03009742.2020.1771761","article-title":"Anti-cyclic citrullinated peptide antibodies are associated with radiographic damage but not disease activity in early rheumatoid arthritis diagnosed in 2006-2011","volume":"49","author":"Ziegelasch","year":"2020","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100291_bib45","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/annrheumdis-2024-eular.2534","article-title":"Factors associated with erosions and joint space narrowing in early rheumatoid arthritis","volume":"83","author":"Miegel","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100291_bib46","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/ard-2023-224728","article-title":"In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation","volume":"83","author":"Pertsinidou","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.jtauto.2025.100291_bib47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/03009742.2017.1416668","article-title":"Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy","volume":"47","author":"Fedele","year":"2018","journal-title":"Scand. J. Rheumatol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib48","first-page":"179","article-title":"Clustering of extraarticular manifestations in patients with rheumatoid arthritis","volume":"35","author":"Turesson","year":"2008","journal-title":"J. Rheumatol."},{"issue":"9","key":"10.1016\/j.jtauto.2025.100291_bib49","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1002\/art.22057","article-title":"Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis","volume":"54","author":"Turesson","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.jtauto.2025.100291_bib50","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.2006.054445","article-title":"Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis","volume":"66","author":"Turesson","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.jtauto.2025.100291_bib52","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3899\/jrheum.101133","article-title":"Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study","volume":"38","author":"Myasoedova","year":"2011","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.jtauto.2025.100291_bib53","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/acr.25231","article-title":"Decline in incidence of extra-articular manifestations of rheumatoid arthritis: a population-based cohort study","volume":"76","author":"Kimbrough","year":"2024","journal-title":"Arthritis Care Res."},{"issue":"11","key":"10.1016\/j.jtauto.2025.100291_bib54","first-page":"2089","article-title":"The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis","volume":"32","author":"Sihvonen","year":"2005","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100291_bib55","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/acr.24071","article-title":"Association of seropositivity and mortality in rheumatoid arthritis and the impact of treatment with disease-modifying antirheumatic drugs: results from a real-world study","volume":"72","author":"Alemao","year":"2020","journal-title":"Arthritis Care Res."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib56","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001142","article-title":"Changes in bone mineral density over 10 years in patients with early rheumatoid arthritis","volume":"6","author":"Theander","year":"2020","journal-title":"RMD Open"},{"issue":"6","key":"10.1016\/j.jtauto.2025.100291_bib57","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/art.41623","article-title":"Association between bone mineral density and autoantibodies in patients with rheumatoid arthritis","volume":"73","author":"Amkreutz","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"11","key":"10.1016\/j.jtauto.2025.100291_bib58","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/acr.21747","volume":"64","author":"Tubach","year":"2012","journal-title":"Arthritis Care Res."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib59","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13075-021-02550-7","article-title":"Predictors of unacceptable pain with and without low inflammation over 5 years in early rheumatoid arthritis-an inception cohort study","volume":"23","author":"Eberhard","year":"2021","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100291_bib60","first-page":"128","article-title":"Disability related to the upper extremities in early rheumatoid arthritis-long-term course and disease variable impact: a cohort study","volume":"52","author":"Rydholm","year":"2025","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.jtauto.2025.100291_bib61","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/acr2.11062","article-title":"The relation between disease activity, patient-reported outcomes, and grip force over time in early rheumatoid arthritis","volume":"1","author":"Rydholm","year":"2019","journal-title":"ACR Open Rheumatol"},{"issue":"2","key":"10.1016\/j.jtauto.2025.100291_bib62","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/rheumatology\/keaa393","article-title":"The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries","volume":"60","author":"Courvoisier","year":"2021","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.jtauto.2025.100291_bib63","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.22025","article-title":"Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks","volume":"54","author":"Cohen","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.semarthrit.2012.11.007","article-title":"Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: systematic review and meta-analysis","volume":"43","author":"Maneiro","year":"2013","journal-title":"Semin. Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100291_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089442","article-title":"The status of rheumatoid factor and anti-cyclic citrullinated peptide antibody are not associated with the effect of anti-TNF\u03b1 agent treatment in patients with rheumatoid arthritis: a meta-analysis","volume":"9","author":"Lv","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jbspin.2013.04.004","article-title":"Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: systematic review and meta-analysis of observational studies","volume":"81","author":"Salgado","year":"2014","journal-title":"Jt. Bone Spine"},{"issue":"3","key":"10.1016\/j.jtauto.2025.100291_bib67","first-page":"455","article-title":"Presence of anti-cyclic citrullinated peptide antibodies is associated with better treatment response to abatacept but not to TNF inhibitors in patients with rheumatoid arthritis: a meta-analysis","volume":"38","author":"Alemao","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000742","article-title":"Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib","volume":"5","author":"Bird","year":"2019","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.jtauto.2025.100291_bib69","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/annrheumdis-2017-212763","article-title":"Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study","volume":"78","author":"Gerlag","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"10429","key":"10.1016\/j.jtauto.2025.100291_bib70","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(23)02650-8","article-title":"Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial","volume":"403","author":"Rech","year":"2024","journal-title":"Lancet"},{"issue":"10429","key":"10.1016\/j.jtauto.2025.100291_bib71","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(23)02649-1","article-title":"Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial","volume":"403","author":"Cope","year":"2024","journal-title":"Lancet"},{"issue":"10348","key":"10.1016\/j.jtauto.2025.100291_bib72","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(22)01193-X","article-title":"Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial","volume":"400","author":"Krijbolder","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jtauto.2025.100291_bib73","article-title":"Hydroxychloroquine does not prevent the future development of rheumatoid arthritis in a population with baseline high levels of antibodies to citrullinated protein antigens and absence of inflammatory arthritis: interim analysis of the StopRA trial","volume":"72","author":"Deane","year":"2024","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"10.1016\/j.jtauto.2025.100291_bib74","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100291_bib75","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100291_bib76","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/ard.2010.131896","article-title":"Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis","volume":"70","author":"Turesson","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.jtauto.2025.100291_bib77","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/art.41402","article-title":"Third-generation anti-cyclic citrullinated peptide antibodies improve prediction of clinical arthritis in individuals at risk of rheumatoid arthritis","volume":"72","author":"Di Matteo","year":"2020","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100291_bib78","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/03009742.2020.1818820","article-title":"Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain","volume":"50","author":"Eloff","year":"2021","journal-title":"Scand. J. Rheumatol."},{"issue":"12","key":"10.1016\/j.jtauto.2025.100291_bib79","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/rheumatology\/kex340","article-title":"The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia","volume":"56","author":"Ten Brinck","year":"2017","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.jtauto.2025.100291_bib80","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/rheumatology\/kex506","article-title":"Can an increase in autoantibody levels predict arthritis in arthralgia patients?","volume":"57","author":"van Beers-Tas","year":"2018","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.jtauto.2025.100291_bib81","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cei.13591","article-title":"Circulating anti-citrullinated protein antibodies containing secretory component are prognostic for arthritis onset in at-risk patients","volume":"204","author":"Roos Ljungberg","year":"2021","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib82","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3899\/jrheum.121313","article-title":"Repeated anticitrullinated protein antibody and rheumatoid factor assessment is not necessary in early arthritis: results from the ESPOIR cohort","volume":"41","author":"Gossec","year":"2014","journal-title":"J. Rheumatol."},{"issue":"11","key":"10.1016\/j.jtauto.2025.100291_bib83","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.3899\/jrheum.110234","article-title":"Should anti-citrullinated protein antibody and rheumatoid factor status be reassessed during the first year of followup in recent-onset arthritis? A longitudinal study","volume":"38","author":"Mjaavatten","year":"2011","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.jtauto.2025.100291_bib84","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3899\/jrheum.120736","article-title":"Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes","volume":"40","author":"Barra","year":"2013","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100291_bib85","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/annrheumdis-2012-202297","article-title":"Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis","volume":"72","author":"B\u00f6hler","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100291_bib86","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/annrheumdis-2014-205698","article-title":"Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial","volume":"75","author":"Kastbom","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100291_bib87","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13075-019-1815-0","article-title":"In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response","volume":"21","author":"de Moel","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"10.1016\/j.jtauto.2025.100291_bib88","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/annrheumdis-2018-214868","article-title":"Does immunological remission, defined as disappearance of autoantibodies, occur with current treatment strategies? A long-term follow-up study in rheumatoid arthritis patients who achieved sustained DMARD-free status","volume":"78","author":"Boeters","year":"2019","journal-title":"Ann. Rheum. Dis."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909025000267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909025000267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T02:58:08Z","timestamp":1750906688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909025000267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":87,"alternative-id":["S2589909025000267"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2025.100291","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies as prognostic markers in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2025.100291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100291"}}